Abstract
Tablet splitting has been a practice widely used. The aim of this work is to investigate the influence of splitting on content uniformity of 25 mg captopril tablets, a common dosage form. Split tablets were obtained by using the hands, a knife or a tablet-splitter. Captopril reference product and two different brands codified as X and Y were used in this study. The method used for quantification was that described in The United States Pharmacopoeia, 30th ed. The results showed that the quality of the analyzed products was affected by splitting processes (by either using the hands, a knife or a tabletsplitter). Nevertheless, the use of tablet splitter produced halves more uniform than the other division processes considered. Moreover, similar products codified as X and Y had a greater discrepancy in content uniformity when knife was used to split the tablets, while splitting the tablets by hands produced the highest variation in the reference product. Considering that lack of information about the split tablets can result in an inadequate therapy, problems related to captopril tablet splitting could be minimized by the distribution of splitting devices.
Keywords: Captopril, content uniformity, pharmaceutical quality control, tablet splitting, tablet-splitter, High performance liquid chromatography
Current Pharmaceutical Analysis
Title:Evaluation of the Influence of Splitting on Content Uniformity of Captopril Tablets
Volume: 9 Issue: 2
Author(s): Fernanda de Lima Moreira, Elisa de Oliveira Silva, Rudy Bonfilio, Olimpia Maria Martins Santos and Magali Benjamim de Araujo
Affiliation:
Keywords: Captopril, content uniformity, pharmaceutical quality control, tablet splitting, tablet-splitter, High performance liquid chromatography
Abstract: Tablet splitting has been a practice widely used. The aim of this work is to investigate the influence of splitting on content uniformity of 25 mg captopril tablets, a common dosage form. Split tablets were obtained by using the hands, a knife or a tablet-splitter. Captopril reference product and two different brands codified as X and Y were used in this study. The method used for quantification was that described in The United States Pharmacopoeia, 30th ed. The results showed that the quality of the analyzed products was affected by splitting processes (by either using the hands, a knife or a tabletsplitter). Nevertheless, the use of tablet splitter produced halves more uniform than the other division processes considered. Moreover, similar products codified as X and Y had a greater discrepancy in content uniformity when knife was used to split the tablets, while splitting the tablets by hands produced the highest variation in the reference product. Considering that lack of information about the split tablets can result in an inadequate therapy, problems related to captopril tablet splitting could be minimized by the distribution of splitting devices.
Export Options
About this article
Cite this article as:
de Lima Moreira Fernanda, de Oliveira Silva Elisa, Bonfilio Rudy, Maria Martins Santos Olimpia and Benjamim de Araujo Magali, Evaluation of the Influence of Splitting on Content Uniformity of Captopril Tablets, Current Pharmaceutical Analysis 2013; 9 (2) . https://dx.doi.org/10.2174/1573412911309020003
DOI https://dx.doi.org/10.2174/1573412911309020003 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Decreased Cerebral Perfusion and Oxidative Stress Result in Acute and Delayed Cognitive Impairment
Current Neurovascular Research Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling
Current Pharmaceutical Design Gene Therapy in Lung Transplantation
Current Gene Therapy Vitamin D3, D2 and Arterial Wall Properties in Coronary Artery Disease
Current Pharmaceutical Design Acute Renal Failure in Different Malignant Tumors
Current Medicinal Chemistry Calcimimetic Drugs and Biomarkers
Recent Patents on Biomarkers Ischemic Neuronal Damage
Current Pharmaceutical Design Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Current Drug Targets - Cardiovascular & Hematological Disorders Stability in Cognitive Function Over 18 Years: Prevalence and Predictors among Older Mexican Americans
Current Alzheimer Research Potential Therapeutic Effects of Exogenous Ketone Supplementation for Type 2 Diabetes: A Review
Current Pharmaceutical Design Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic
Reviews on Recent Clinical Trials Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology 21-Hydroxy-6,19-epoxyprogesterone: A Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action
Mini-Reviews in Medicinal Chemistry Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology Antineutrophil Cytoplasmic Antibody in Lupus Nephritis: Correlation with Clinicopathological Characteristics and Disease Activity
Current Rheumatology Reviews Editorial [Hot Topic: Experimental Models for the Study of Drugs Used to Prevent and Treat Vascular Diseases (Executive Editors: C.S. Thompson, D.P. Mikhailidis and K.I. Paraskevas)]
Current Pharmaceutical Design Low Estimated Glomerular Filtration Rate is Associated with High Recurrence Rate and Poor Prognosis of Hemorrhage Stroke
Current Neurovascular Research NOS: Molecular Mechanisms, Clinical Aspects, Therapeutic and Monitoring Approaches
Current Drug Targets - Inflammation & Allergy Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation
Mini-Reviews in Medicinal Chemistry Anti-IL-1 β Therapies
Recent Patents on DNA & Gene Sequences